Completed NA INTERVENTIONAL 1-arm NCT01793792

Pivotal Study of the LVIS (Low Profile Visualized Intraluminal Support) (LVIS)

Pivotal Study of the Microvention, Inc Neurovascular Self-Expanding Retrievable Stent System LVIS

Sponsor: Microvention-Terumo, Inc.

Updated 9 times since 2017 Last updated: Jun 13, 2025 Started: Jul 31, 2013 Primary completion: Nov 30, 2015 Completion: Jan 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01793792, this NA trial focuses on Intracranial Aneurysms and remains completed. Sponsored by Microvention-Terumo, Inc., it has been updated 9 times since 2013, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

9 versions recorded

Jul 2025 — Present [monthly]

Completed NA
Sep 2024 — Jul 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Dec 2019 — Jan 2021 [monthly]

Completed NA

▶ Show 4 earlier versions

Jun 2018 — Dec 2019 [monthly]

Completed NA
Apr 2018 — Jun 2018 [monthly]

Completed NA

Phase: PHASE3 → NA
Feb 2017 — Apr 2018 [monthly]

Completed PHASE3
Jan 2017 — Feb 2017 [monthly]

Completed PHASE3

First recorded

Jul 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Microvention-Terumo, Inc.

Data source: Microvention-Terumo, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Albany, United States , Baltimore, United States , Boston, United States , Buffalo, United States , Carmichael, United States , Charleston, United States , Chicago, United States , Cleveland, United States , Englewood, United States , Houston, United States and 10 more locations